Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Cyclo(-RGDfK) Peptide, CAS 161552-03-0 | Integrin Inhibitor

Cyclo(-RGDfK), CAS 161552-03-0 US$1,096.75 Excluding tax and shipping fees In stock Description About Cyclo(-RGDfK), CAS 161552-03-0 Cyclo(-RGDfK), CAS 161552-03-0 is a potent/selective inhibitor of integrin αvβ3 binding for cancer-targeting research. The Cycl

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Cyclo(-RGDfK), CAS 161552-03-0

US$1,096.75

Excluding tax and shipping fees

In stock

Description

About Cyclo(-RGDfK), CAS 161552-03-0

Cyclo(-RGDfK), CAS 161552-03-0 is a potent/selective inhibitor of integrin αvβ3 binding for cancer-targeting research. The Cyclo(-RGDfK), CAS 161552-03-0 Peptide, RGDfK (cyclic peptide, head-to-tail) from JPT is produced under strict quality control and quality management.

Cyclo(-RGDfK), CAS 161552-03-0- Specifications

Peptide sequence: RGDfK (cyclic peptide, head-to-tail)

Amount: 1 mg

Purity: > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): Cancer research

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for Cyclo(-RGDfK), CAS 161552-03-0

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for Cyclo(-RGDfK), CAS 161552-03-0

GRGD-acid - CAS 97461-81-9.pdf

Properties

Properties of Cyclo(-RGDfK), CAS 161552-03-0

1 mg

Cancer peptides

Cancer

Freeze-dried in plastic vial

Artificial

Other

>90% (HPLC-MS)

No

Further Information to Cyclo(-RGDfK), CAS 161552-03-0

Values

RGDfK (cyclic peptide, head-to-tail)

cyclized RGD cancer peptide

Related Products

Related Products

GRGD-acid, CAS 97461-81-9

US$177.67

GRGDSP, CAS 91037-75-1

US$282.50

RGD-4C, CAS 332179-76-7

[Pyr 1]-Apelin-13, CAS 217082-60-5

US$186.52

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →